Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: anatomical and subcellular distribution.
about
Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligandImaging neuroinflammation in multiple sclerosis using TSPO-PETTowards molecular imaging of multiple sclerosis.Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation.Synthesis and evaluation of translocator 18 kDa protein (TSPO) positron emission tomography (PET) radioligands with low binding sensitivity to human single nucleotide polymorphism rs6971.Development of N-methyl-(2-arylquinolin-4-yl)oxypropanamides as leads to PET radioligands for translocator protein (18 kDa).Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography.Changes in [3H]-PK 11195 and [3H]-8-OH-DPAT binding following forebrain ischaemia in the gerbilKinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation.[¹¹C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approachesQuantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06.Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [11C]CB184, in healthy human volunteers.Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data.Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [11 C]PBR28.In vivo PET imaging of neuroinflammation in Alzheimer's disease.In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [(11)C](R)-PK11195 positron emission tomography study.Preclinical and first-in-man studies of [(11)C]CB184 for imaging the 18-kDa translocator protein by positron emission tomography.In vitro quantitative autoradiography of [3H]-L-deprenyl and [3H]-PK 11195 binding sites in human epileptic hippocampus.Differential binding properties of the peripheral-type benzodiazepine ligands [3H]PK 11195 and [3H]Ro 5-4864 in trout and mouse brain membranes.PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia.Assessment of the Protection of Dopaminergic Neurons by an α7 Nicotinic Receptor Agonist, PHA 543613 Using [(18)F]LBT-999 in a Parkinson's Disease Rat Model.Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects.PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.Are prescribed benzodiazepines likely to affect the availability of the 18 kDa translocator protein (TSPO) in PET studies?Translocator protein ligands based on N-methyl-(quinolin-4-yl)oxypropanamides with properties suitable for PET radioligand development.Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.Validation of an automatic reference region extraction for the quantification of [18F]DPA-714 in dynamic brain PET studies.Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28.Macrophage and astrocyte populations in relation to [3H]PK 11195 binding in rat cerebral cortex following a local ischaemic lesion.Regulation of synaptic plasticity by hippocampus synthesized estradiol.In vivo binding to peripheral benzodiazepine binding sites in lesioned rat brain: comparison between [3H]PK11195 and [18F]PK14105 as markers for neuronal damage.Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study.Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography.Cellular Sources and Regional Variations in the Expression of the Neuroinflammatory Marker Translocator Protein (TSPO) in the Normal Brain
P2860
Q24671763-E556A90E-6065-4F24-A775-D8B51FABB145Q28084625-137ACD77-79D6-488B-BF94-9894C4632744Q33787779-AF89FF5B-0F9D-488D-9922-C3BCD14EF569Q34171364-C186A480-FCF3-4A36-8ED9-B37E21AA2A78Q34408079-F667105F-C023-449D-8389-DB8331F6E631Q34435657-C5E82F18-2284-4DF2-BE95-2B32893F1F7BQ35208026-AA5AA685-FC14-4A5D-9A9C-F35FE7EA1928Q36329590-88622CB2-7BBE-40CF-9894-7431D470401FQ36492494-F997BC98-F1DB-45BB-8DD1-27D238D0DDB5Q37083488-A7DAAC6B-392E-48C2-A4E8-C396645820A6Q37449735-6E40636A-CE4A-458A-89BA-0896370C7F1AQ37718960-FC05B132-EC89-4FAC-AD1F-0FB7B50F8349Q38667002-9C59E868-19CA-4CA4-AFB6-8C116EDD3CE1Q38714486-773FA3EB-D881-43F7-A96B-9A5E0302CD1FQ38779574-7281DB9F-486F-4058-B8D3-D24C9F1690B0Q39326557-046963F2-0580-4929-8337-9669E66A6FC2Q39666235-CF63663A-0DE4-41ED-8F24-B6F834CA875EQ41114505-C2CED4D7-597A-4953-9051-A22428E37ED9Q41315477-05CA4900-0CFF-48A0-919C-83CCB1343FBAQ41687400-A62F5C9A-5726-465F-8DE9-241C162929D6Q41778722-D8A68D7D-2C35-4C2B-A3DE-F49CAA5DBAE2Q42158298-2DC4493C-2EF7-4AC6-9B0E-81A21E77AC79Q44444454-94E34971-0331-40EB-9A1D-769A4D1A8C1DQ45787444-478EA7BB-410D-4544-AF14-2D5D6897E1D9Q46087990-1163F776-084D-434D-8D65-7B4268B68406Q46706023-63EE66B6-C757-4853-AA5F-A6D7D5CBBF1BQ47979574-AA551E35-8E27-4DE2-91DE-9D40571BBF9BQ48310692-B8A597FA-9FA4-4DAC-8753-5917F8A45353Q48783677-97F2667D-9BB2-49A0-8060-B46928A7634AQ48922535-FF7F589D-F95E-4F6E-A161-16390EB7867FQ48940280-4334ADD4-9D5E-4AD6-92AB-F36DD833BC50Q48952718-9FDF22EF-8B5C-45C4-BBC5-9C751466915DQ52597663-400B176F-EFC3-4A37-B466-CEFCEFE04DD0Q58749701-4EFBC562-8655-4D63-91B8-25D3BFA0BC17
P2860
Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: anatomical and subcellular distribution.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Labelling of peripheral-type b ...... and subcellular distribution.
@ast
Labelling of peripheral-type b ...... and subcellular distribution.
@en
type
label
Labelling of peripheral-type b ...... and subcellular distribution.
@ast
Labelling of peripheral-type b ...... and subcellular distribution.
@en
prefLabel
Labelling of peripheral-type b ...... and subcellular distribution.
@ast
Labelling of peripheral-type b ...... and subcellular distribution.
@en
P2093
P1476
Labelling of peripheral-type b ...... and subcellular distribution.
@en
P2093
C Malgouris
P356
10.1016/0361-9230(87)90033-5
P577
1987-01-01T00:00:00Z